QDEL: QuidelOrtho Corporation Stock

by  •  • Comments Off on QDEL: QuidelOrtho Corporation Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 2,649.73
Enterprise Value ($M) 4,945.43
Book Value ($M) 5,005.90
Book Value / Share 74.85
Price / Book 0.53
NCAV ($M) -2,246.70
NCAV / Share -33.59
Price / NCAV -1.18

Profitability (mra)
Return on Invested Capital (ROIC) -0.00
Return on Assets (ROA) -0.00
Return on Equity (ROE) -0.00

Liquidity (mrq)
Quick Ratio 0.88
Current Ratio 1.57

Balance Sheet (mrq) ($M)
Current Assets 1,310.50
Assets 8,563.10
Liabilities 3,557.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,997.80
Operating Income 252.50
Net Income -10.10
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 280.20
Cash from Investing -187.60
Cash from Financing -265.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A T. Rowe Price Investment Management, Inc. 13.00 30.68
02-13 13G/A Vanguard Group Inc 7.25 0.89
01-26 13G/A BlackRock Inc. 7.20 -4.39

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 71,319 448,663 15.90
2024-04-25 158,468 788,122 20.11
2024-04-24 111,880 453,726 24.66
2024-04-23 147,006 414,041 35.51
2024-04-22 131,050 407,808 32.14

(click for more detail)

Similar Companies
PRTA – Prothena Corporation plc PTCT – PTC Therapeutics, Inc.
PYXS – Pyxis Oncology, Inc. QNCX – Quince Therapeutics, Inc.
QURE – uniQure N.V.


Financial data and stock pages provided by
Fintel.io